Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Deep learning algorithms and Raman spectroscopy in the clinical laboratory setting164
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review73
Data analytics for error detection in clinical laboratories64
The anion gap as a predictive tool for morbidity and mortality53
Machine learning-based error detection in the clinical laboratory: a critical review47
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath42
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease39
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application37
Transthyretin mutagenesis: impact on amyloidogenesis and disease35
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications35
Clinical utility of human epididymis protein 433
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology30
Evaluating thyroid function in pregnant women30
Comparison of liquid biopsy-based technologies for cancer screening29
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker26
Beyond newborn screening: the role of reverse cascade testing in familial disease detection26
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation26
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration23
Cardiovascular disease lipids and lipoproteins biomarker standardization23
One health and laboratory medicine: challenges and perspectives for antimicrobial resistance, emerging infections, and food/water security20
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-1919
Association of inflammatory biomarkers with morbidity and mortality risk in patients with peripheral artery disease: a systematic review and ­meta-analysis19
Challenges of insulin-like growth factor-1 testing19
Emerging applications of machine learning in genomic medicine and healthcare18
Omics-based computational approaches for biomarker identification, prediction, and treatment of Long COVID18
Analytical and clinical considerations of synovial fluid calprotectin in diagnosing periprosthetic joint infections18
Using a systematic approach to strategic innovation in laboratory medicine to bring about change17
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future16
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?15
Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: a clinical review15
The intersection of the laboratory and transgender care15
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis14
The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor14
Guidelines for diagnosing and differentiating infection with antifungal-resistant Trichophyton indotineae from other dermatophytoses14
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders14
Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?13
Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review13
0.07320499420166